Glenmark Pharmaceuticals has informed that it attached media release on 21st September 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%’.
The above information is a part of company’s filings submitted to BSE.